Incyte
INCY
#1061
Rank
S$29.38 B
Marketcap
S$147.07
Share price
5.78%
Change (1 day)
69.27%
Change (1 year)

Incyte (INCY) - Net assets

Net assets on the balance sheet as of March 2026 : S$7.27 Billion

According to Incyte's latest financial reports the company has S$7.27 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Incyte - Net assets on balance sheet (from 2001 to 2026)

Net assets by year

Year Net assets Change
2025-12-31$S$6.63 B41.57%
2024-12-31$S$4.68 B-31.63%
2023-12-31$S$6.85 B16.99%
2022-12-31$S$5.85 B14.95%
2021-12-31$S$5.09 B47.54%
2020-12-31$S$3.45 B-1.39%
2019-12-31$S$3.50 B33.14%
2018-12-31$S$2.63 B20.64%
2017-12-31$S$2.18 B259.25%
2016-12-31$S$0.60 B150.76%
2015-12-31$S$0.24 B-324.46%
2014-12-31$-S$0.11 Billion-55.92%
2013-12-31$-S$0.25 Billion14.35%
2012-12-31$-S$0.22 Billion-27.25%
2011-12-31$-S$0.3 Billion157.55%
2010-12-31$-S$0.12 Billion-20.56%
2009-12-31$-S$0.15 Billion-54.47%
2008-12-31$-S$0.32 Billion37.53%
2007-12-31$-S$0.23 Billion76.3%
2006-12-31$-S$0.14 Billion303.14%
2005-12-31$-S$32.3 Million-125.21%
2004-12-31$S$0.12 B-51.15%
2003-12-31$S$0.26 B-50.03%
2002-12-31$S$0.52 B-35.61%
2001-12-31$S$0.81 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Novartis
NVS
S$50.33 B 592.30%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
S$116.88 B 1,507.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$40.33 B 454.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$11.88 B 63.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
S$1.28 B-82.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
S$0.29 B-95.98%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
-S$32.78 Million-100.45%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
S$37.29 M-99.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
S$0.19 B-97.36%๐Ÿ‡บ๐Ÿ‡ธ USA